Infection prevention strategies in a stem cell transplant unit: Impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality

European Journal of Haematology

Volumn 83, Issue 2, 2009, Pages 130-138

  Cantoni, Nathan ^a   Weisser, Maja ^a   Buser, Andreas ^a   Arber, Caroline ^a   Stern, Martin ^a   Heim, Dominik ^a   Halter, Jörg ^a   Christen, Susanne ^a   Tsakiris, Dimitrios A ^a   Droll, Armin ^a,c   Frei, Reno ^a   Widmer, Andreas F ^a   Flückiger, Ursula ^a   Passweg, Jakob ^a,b   Tichelli, André ^a   Gratwohl, Alois ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Dornach Hospital   (Switzerland)

Author keywords

Hematological stem cell transplantation; Immunoglobulins; Infection rate; Sterile care; Tent

Indexed keywords

ACICLOVIR; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUCONAZOLE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; REDIMUNE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VALACICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG USE; FEMALE; HERPES; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; INFECTION RATE; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; SEPSIS; SURVIVAL RATE; TOXOPLASMOSIS;

ADOLESCENT; ADULT; COHORT STUDIES; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFECTION; INFECTION CONTROL; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 67650708739     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01249.x     Document Type: Article

References (41)

1. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007 357 : 1472 5.
2. Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982 60 : 714 20.
3. Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K, Noel D, Thomas ED. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979 53 : 720 31.
4. Aucouturier P, Barra A, Intrator L, Cordonnier C, Schulz D, Duarte F, Vernant JP, Preud'homme JL. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987 70 : 779 85.
5. Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host disease and low serum IgG. Blood 1988 72 : 621 7.
6. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987 69 : 369 80.
7. Sheridan JF, Tutschka PJ, Sedmak DD, Copelan EA. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. Blood 1990 75 : 1583 6.
8. Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991 28 : 250 9.
9. Witherspoon RP, Storb R, Ochs HD, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 1981 58 : 360 8.
10. Lampert IA, Moore RH, Huby R, Cohen J. Observations on the role of endotoxin in graft-versus-host disease. Prog Clin Biol Res 1988 272 : 351 9.
11. Rhodes LE, van Saene HK, White S, Fairclough S, Ball LM, Martin J. Microbial carriage, sepsis, infection and acute GVHD in the first 25 BMT at the Royal Liverpool Children's Hospital. Bone Marrow Transplant 1993 11 : 261 9.
12. Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991 325 : 110 7.
13. Winston DJ, Ho WG, Lin CH, Bartoni K, Budinger MD, Gale RP, et al. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 1987 106 : 12 8.
14. Winston DJ, Ho WG, Lin CH, Budinger MD, Champlin RE, Gale RP. Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial. Am J Med 1984 76 : 128 33.
15. Sullivan KM, Kopecky KJ, Jocom J, et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990 323 : 705 12.
16. Cordonnier C, Chevret S, Legrand M, Rafi H, Dhedin N, Lehmann B, Bassompierre F, Gluckmann E. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 2003 139 : 8 18.
17. Dykewicz CA. Hospital infection control in hematopoietic stem cell transplant recipients. Emerg Infect Dis 2001 7 : 263 7.
18. Passweg JR, Gratwohl A, Tichelli A, et al. [25 years allogenic bone marrow transplantation in Basel: 1973-1998]. Schweiz Med Wochensch 1998 128 : 1568 74.
19. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000 49 (RR-10) : 1 95.
20. Heim D, Passweg J, Gregor M, Buser A, Theocharides A, Arber C, et al. Patient and product factors affecting platelet transfusion results. Transfusion 2008 48 : 681 7.
21. Center for Disease Control and Prevention - Atlanta U. Guidelines for prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep 2002 51 : 1 36.
22. Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen am Institut für Hygiene UBF, Freie Universität Berlin und Zentralbereich Krankenhaushygiene, Universitätsklinikum Charité, Humboldt-Universität Berlin. Modul OnkoKISS Protokoll: Surveillance- Protokoll für Knochenmark- und Blutstammzell-Transplantationen. 2003.
23. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34 : 7 14. (Pubitemid 33152659)
24. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002 34 : 1094 7.
25. Armitage JO. Bone marrow transplantation. N Engl J Med 1994 330 : 827 38.
26. Tiercy JM, Nicoloso G, Passweg J, et al. The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant 2007 40 : 515 22.
27. Schimpff SC, Greene WH, Young VM, Fortner CL, Cusack N, Block JB, Wiemik PH. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med 1975 82 : 351 8.
28. Ueda T, Shibata H, Nakamura H, et al. Efficacy of laminar air flow room with or without clean nursing for preventing infection in patients with acute leukemia. Jpn J Clin Oncol 1983 13 (Suppl. 1 151 7.
29. Passweg JR, Rowlings PA, Atkinson KA, et al. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1998 21 : 1231 8.
30. Petersen FB, Buckner CD, Clift RA, et al. Laminar air flow isolation and decontamination: a prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients. Infection 1986 14 : 115 21.
31. Petersen FB, Buckner CD, Clift RA, Nelson N, Counts GW, Meyers JD, Thomas ED. Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scand J Infect Dis 1987 19 : 559 67.
32. Petersen F, Thornquist M, Buckner C, Counts G, Nelson N, Meyers J, Clift R, Thomas E. The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection 1988 16 : 199 208. (Pubitemid 18197470)
33. Nagao T. Experience with protective isolation for infection prevention in the compromised host. Tokai J Exp Clin Med 1986 11 (Suppl 23 8.
34. Skinhoj P, Jacobsen N, Hoiby N, Faber V. Strict protective isolation in allogenic bone marrow transplantation: effect on infectious complications, fever and graft versus host disease. Scand J Infect Dis 1987 19 : 91 6.
35. Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Farewell VT, Thomas ED. Protective environment for marrow transplant recipients: a prospective study. Ann Intern Med 1978 89 : 893 901. (Pubitemid 9087323)
36. Russell JA, Poon MC, Jones AR, Woodman RC, Ruether BA. Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease. Lancet 1992 339 : 38 40.
37. Guerra IC, Shearer WT. Environmental control in management of immunodeficient patients: experience with "David". Clin Immunol Immunopathol 1986 40 : 128 35.
38. Raanani P. Immunoglobulin propyhlaxis in hematological malignancies and hematopoietic stem cell transplantation. The Cochrane Database Syst Rev. 2008 4 : CD006501.
39. Arber C, Buser A, Heim D, Weisser M, Tyndall A, Tichelli A, Passweg J, Gratwohl A. Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment. Bone Marrow Transplant 2007 40 : 597 8.
40. Dettenkofer M, Wenzler-Rottele S, Babikir R, Bertz H, Ebner W, Meyer E, Ruden H, Gastmeier JP, Daschner FD. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 2005 40 : 926 31.
41. Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 2007 40 : 63 70. (Pubitemid 47018415)